David S. Moura

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

Javier Martín‐Broto, Nadia Hindi, Giovanni Grignani et al. · Journal for ImmunoTherapy of Cancer · 2020 · 169 citations · Full text

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Silvia Stacchiotti, Antonio López–Pousa et al. · The Lancet Oncology · 2018 · 131 citations

Surgical Oncology, Medicine, Metronomic Therapy +5

VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage

Marcella Salzano, Marta Sanz-García, Diana M. Monsalve et al. · Epigenetics · 2015 · 96 citations · Full text

Histone Modifications, Dna Damage, Vrk1 Chromatin Kinase +22

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel et al. · The Lancet Oncology · 2020 · 84 citations

Surgical Oncology, Medicine, Systemic Treatment +5

VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis

David S. Moura, Ignacio Campillo‐Marcos, Marta Vázquez-Cedeira et al. · Cellular and Molecular Life Sciences · 2018 · 76 citations · Full text